19
CB1 expression in DRGs N F200 IB4 CGRP (Bridgesetal2003) CB1 in red O therm arkersin green Colocalizationin yellow Control N F200 IB4 CGRP (Bridgesetal2003) CB1 in red O therm arkersin green Colocalizationin yellow Control

CB1 expression in DRGs

Embed Size (px)

DESCRIPTION

CB1 expression in DRGs. (Pertwee 2009). Pharmacological tools. Selectivity and affinity of CB1 agonists are suboptimal. DRG. Spinal cord. (Agarwal et al 2007). CB1-mediated nociception. Sensory neurons specific CB1 KO. Expression in DRG. Expression in brain. (Agarwal et al 2007). - PowerPoint PPT Presentation

Citation preview

Page 1: CB1 expression in DRGs

CB1 expression in DRGs

NF200 IB4

CGRP

(Bridges et al 2003)

CB1 in redOther markers in greenColocalization in yellow

Control

NF200 IB4

CGRP

(Bridges et al 2003)

CB1 in redOther markers in greenColocalization in yellow

Control

Page 2: CB1 expression in DRGs

Pharmacological tools

Selectivity and affinity of CB1 agonists are suboptimal

(Pertwee 2009)

Page 3: CB1 expression in DRGs

CB1-mediated nociception

Sensory neurons specific CB1 KO

(Agarwal et al 2007)

DRG Spinal cord

Page 4: CB1 expression in DRGs

(Agarwal et al 2007)

Expression in DRG Expression in brain

CB1-mediated nociceptionSensory neurons specific CB1 KO

Page 5: CB1 expression in DRGs

CB1-mediated nociception

(Agarwal et al 2007)

Nociceptive response (acute pain) and locomotor performance

Page 6: CB1 expression in DRGs

CB1-mediated nociception

(Agarwal et al 2007)

Nociceptive response (inflammatory pain)

Page 7: CB1 expression in DRGs

CB1-mediated nociception

(Agarwal et al 2007)

Effect of WIN55212-2 on inflammatory pain

Page 8: CB1 expression in DRGs

CB1-mediated nociception

(Agarwal et al 2007)

Effect of intrathecal vs intraplantar administration of WIN55212-2

Page 9: CB1 expression in DRGs

CB1-induced nociception: mechanism of action

• Two potential sites of action:– DRG: nociception– CNS: processing of nociceptive information

• Action on DRG blocks pain transmission to the CNS

• Action on the CNS may modulate nociceptive input elaboration

Page 10: CB1 expression in DRGs

CB2-mediated nociception

Page 11: CB1 expression in DRGs

CB2 synthetic agonists

(Beltramo 2009)

Bicyclic cannabinoid:HU308 (1)Cannabinor (2)

THC derivatives:JWH133 (3)

Aminoalkylindoles:AM1241 (4)L768242 (5)A-796260 (6)

Pyrimidine derivatives:GW842166X (7)

Thiazole derivatives:A-836339 (8)

Carboxiamide derivatives:Taisho (9)

Thiazine derivatives:Shonogi (10)

Page 12: CB1 expression in DRGs

CB2-mediated nociception

(Hanuš et al 1999)

Page 13: CB1 expression in DRGs

CB2-mediated nociception

Effect on neuropathic pain

(Ibrahim et al. 2003)

AM1241

Page 14: CB1 expression in DRGs

CB2-mediated nociception

(Ibrahim et al. 2003)

Sham-operated wt Spinal nerve ligated wt

Spinal nerve ligated CB1 KOSham-operated CB1 KO

Effect on neuropathic pain

Page 15: CB1 expression in DRGs

Effect on neuropathic pain

CB2-mediated nociception

(Beltramo et al. 2006)

Reduction of mechanical allodynia in SNL rat

Page 16: CB1 expression in DRGs

CB2-mediated nociception:cellular mechanisms

(Ibrahim et al. 2006)Release from paw skin

AM1241 antihyperalgesic effect in μ-opiod receptor wt and KO mice

Page 17: CB1 expression in DRGs

CB2 localization

(Zhang et al 2003)

Expression in spinal cord

Page 18: CB1 expression in DRGs

CB2 localization

Contralateral

CB2 in situ hybridization in the dorsal horn

Ipsilateral

CB2 CB2 OX42

(Zhang et al. 2003)

Page 19: CB1 expression in DRGs

Summary and perspectives

• The cannabinoid system play an important role in nociception• The research to develop a cannabinoid analgesic has made

significant progress

• CB2 agonist and mixed peripherally restricted agonists are at present the most promising strategies

• Research on the inactivation system is progressing and show interesting potential

• Side effects and regulatory constrain remain important issues to be solved